Sio Capital Management »

Monopar Therapeutics shares owned by Sio Capital Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.5M 174k 54.79

More positions owned by Sio Capital Management

Maximus (MMS)
Waystar Holding Corp (WAY)
Icon SHS (ICLR)
AmerisourceBergen (COR)
Dianthus Therapeutics (DNTH)
Anteris Technologies Global (AVR)
Corcept Therapeutics Incorporated (CORT)
Livanova SHS (LIVN)
Tyra Biosciences (TYRA)
Celcuity (CELC)
GSK Sponsored Adr (GSK)
Biosante Pharmaceuticals (ANIP)
Abbott Laboratories (ABT)
Embecta Corp Common Stock (EMBC)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Sio Capital Management

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Saturn V Capital Management
Deerfield Management Company
BlackRock
Adage Capital Partners GP
Vanguard Group
ADAR1 Capital Management
Vanguard Capital Management
Siren
Wellington Management Company
Sio Capital Management
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings

View all funds holding Monopar Therapeutics